Release Date: 23/04/18 08:50 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 356.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%